MedPath

Microcrystalline cellulose

Generic Name
Microcrystalline cellulose
Drug Type
Small Molecule
CAS Number
9004-34-6
Unique Ingredient Identifier
BX81F82EWG
Background

A polysaccharide with glucose units linked as in CELLOBIOSE. It is the chief constituent of plant fibers, cotton being the purest natural form of the substance. As a raw material, it forms the basis for many derivatives used in chromatography, ion exchange materials, explosives manufacturing, and pharmaceutical preparations.

Indication

用于体表创伤、外科创面止血及上消化道出血。

Associated Conditions
Vaginal burning sensation, Vaginal itching

Reducing Frailty for Older Cancer Survivors Using Supplements II

Phase 2
Recruiting
Conditions
Inflammation
Frailty
Interventions
First Posted Date
2023-10-05
Last Posted Date
2025-01-29
Lead Sponsor
University of Rochester
Target Recruit Count
118
Registration Number
NCT06068543
Locations
🇺🇸

University of Rochester, Rochester, New York, United States

KAND567 Versus Placebo in Subjects Hospitalized With COVID-19

Phase 2
Terminated
Conditions
Covid19
Interventions
First Posted Date
2023-08-25
Last Posted Date
2023-08-25
Lead Sponsor
Kancera AB
Target Recruit Count
35
Registration Number
NCT06012565
Locations
🇩🇰

Odense University Hospital, Odense, Denmark

🇩🇰

Hvidovre Hospital, Hvidovre, Denmark

🇸🇪

Västmanlands Hospital, Västerås, Sweden

and more 1 locations

The Use of Naltrexone Hydrochloride to Promote Healing in Patients With Resistant Non-infectious Corneal Ulcer

Not Applicable
Completed
Conditions
Cornea Ulcer
Interventions
First Posted Date
2023-06-29
Last Posted Date
2023-06-29
Lead Sponsor
Minia University
Target Recruit Count
50
Registration Number
NCT05924893
Locations
🇪🇬

Faculty of Medicine, Minya, Egypt

Investigation of the Efficacy of Metformin Therapy on Pulmonary Sarcoidosis

Phase 2
Withdrawn
Conditions
Sarcoidosis, Pulmonary
Interventions
First Posted Date
2023-06-18
Last Posted Date
2025-02-11
Lead Sponsor
University of Maryland, Baltimore
Target Recruit Count
40
Registration Number
NCT05910554

Effectiveness of Food-grown Magnesium on Sleep Quality/Quantity

Phase 3
Completed
Conditions
Sleep
Interventions
Drug: Food-Grown Magnesium
First Posted Date
2023-04-24
Last Posted Date
2023-10-24
Lead Sponsor
RDC Clinical Pty Ltd
Target Recruit Count
84
Registration Number
NCT05825209
Locations
🇦🇺

RDC Global Pty Ltd, Brisbane, Queensland, Australia

Efficacy and Safety of Sibutramin-containing Drugs in Patient With Alimentary Obesity

Phase 4
Completed
Conditions
Obesity
Interventions
First Posted Date
2023-04-20
Last Posted Date
2023-04-24
Lead Sponsor
Promomed, LLC
Target Recruit Count
240
Registration Number
NCT05821543
Locations
🇷🇺

Ivanovo Clinical Hospital named after Kuvaev, Ivanovo, Russian Federation

🇷🇺

Kirov State Medical University, Kirov, Russian Federation

🇷🇺

Pirogov Russian National Research Medical University, Moscow, Russian Federation

and more 5 locations

Effectiveness of PEA Compared to Placebo on Acute Menstrual Pain

Phase 4
Completed
Conditions
Menstrual Pain
Interventions
First Posted Date
2023-04-12
Last Posted Date
2024-11-14
Lead Sponsor
RDC Clinical Pty Ltd
Target Recruit Count
80
Registration Number
NCT05810116
Locations
🇦🇺

RDC Clinical Pty Ltd, New Farm, Queensland, Australia

Effectiveness of Testofen Compared to Placebo on Long COVID Symptoms

Phase 3
Completed
Conditions
Long Covid19
Interventions
First Posted Date
2023-04-03
Last Posted Date
2025-03-10
Lead Sponsor
RDC Clinical Pty Ltd
Target Recruit Count
150
Registration Number
NCT05795816
Locations
🇦🇺

RDC Clinical Pty Ltd, Brisbane, Queensland, Australia

An Evaluation of Psilocybin's Effect on Cardiac Repolarization and the Effect of Food on Psilocybin's Pharmacokinetics

Phase 1
Completed
Conditions
QTc Interval
Pharmacokinetics
Interventions
First Posted Date
2022-07-28
Last Posted Date
2023-08-15
Lead Sponsor
Usona Institute
Target Recruit Count
60
Registration Number
NCT05478278
Locations
🇺🇸

Altasciences Clinical Kansas, Inc, Overland Park, Kansas, United States

Low Dose Naltrexone Use in Patients With POTS

Phase 4
Not yet recruiting
Conditions
Postural Orthostatic Tachycardia Syndrome
Interventions
First Posted Date
2022-05-06
Last Posted Date
2024-05-09
Lead Sponsor
University of Calgary
Target Recruit Count
80
Registration Number
NCT05363514
© Copyright 2025. All Rights Reserved by MedPath